John Lechleiter, the CEO of Eli Lilly and Co., is calling for the creation of a “world-class” research institute in Indianapolis to bring together scientists from universities and corporations to develop new medical therapies and companies.
He said Lilly would commit an unspecified amount of money to sponsor research at the new institute as well as allowing its scientists to participate in collaborations at the institute.
“I sort of see it as the kettle on the stove. It’s boiling, it’s just brimming over with ideas,” Lechleiter said of the research institute he has in mind, which he compared to the Broad Institute in Massachusetts or the Scripps Research Institute in San Diego.
The research institute idea, which Lechleiter hopes gets launched by state, university and corporate leaders within the next year, was part of a broader charge he gave leaders in Indiana to redouble their efforts to grow life sciences businesses here.